MAPT and Alzheimer disease: The pathophysiology of AD is considered a molecular–metabolic dysfunction within the brain, in which the formation of beta amyloid plaques (Ab) and neurofibrillary tangles caused by the aggregation of beta-amyloid peptides and tau proteins, respectively, appear to be the key features involved.